Bitte beachten Sie: Im Zeitraum vom 21.12.2024 bis zum 07.01.2025 werden auf hohPublica keine Anfragen oder Publikationen durch das KIM bearbeitet. Please note: KIM will not process any requests or publications on hohPublica between December 21, 2024 and January 7, 2025.
 

A new version of this entry is available:

Loading...
Thumbnail Image
ResearchPaper
2013

Which form of venture capital is most supportive of innovation? : Evidence from European biotechnology companies

Abstract (English)

We argue that different forms of venture capital contribute differently to the innovation process and, consequently, differ in their impact on portfolio companies? innovation output. Our results suggest that the innovation output of companies financed by independent VCs increases significantly faster than that of both non-VC-backed companies and of companies financed by governmental VCs. However, governmental VCs may be beneficial for innovation by complementing the skills and resources provided by an independent VC in a heterogeneous syndicate.

File is subject to an embargo until

This is a correction to:

A correction to this entry is available:

This is a new version of:

Notes

Die Volltext-Datei ist nur im Campusnetz verfügbar.
The full text file is only available on the campus network.
Publication license

Publication series

FZID discussion papers; 69

Published in

Faculty
Faculty of Business, Economics and Social Sciences
State Institutes
Institute
Institute of Financial Management
Forschungszentrum Innovation und Dienstleistung

Examination date

Supervisor

Edition / version

Citation

DOI

ISSN

ISBN

Language
English

Publisher

Publisher place

Classification (DDC)
330 Economics

Original object

Free keywords

Standardized keywords (GND)

Sustainable Development Goals

BibTeX

@techreport{Tykvová2013, url = {https://hohpublica.uni-hohenheim.de/handle/123456789/5690}, author = {Tykvová, Tereza and Bertoni, Fabio}, title = {Which form of venture capital is most supportive of innovation? : Evidence from European biotechnology companies}, year = {2013}, school = {Universität Hohenheim}, series = {FZID discussion papers}, }
Share this publication